Emerging Infectious Disease Diagnostics Market
完整報告名稱與涵蓋範圍
Emerging Infectious Disease Diagnostics Market Size, Share & Trends Analysis Report By Application (Laboratory Testing and Point-of-Care Testing), Technology, Type of Infection, Disease Type, End Users, Region, And Segment Forecasts, 2023-2031
報告摘要
The global Emerging Infectious Disease Diagnostics Market is set to expand at a compound annual growth rate of 5.9% throughout the 2023–2031 forecast period.
Emerging Infectious Disease Diagnostics encompasses a diagnostic procedure in which various diagnostic tools are used to detect and characterise the causative organisms of infectious diseases. The sector has gained traction as organizations seek innovative approaches to address evolving healthcare challenges.
Several factors contribute to this trajectory, including heightened appetite for next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
From a regional perspective, mature markets in North America and Europe continue to hold marked shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and growing investment in the sector.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Emerging Infectious Disease Diagnostics Market Snapshot
Chapter 4. Global Emerging Infectious Disease Diagnostics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis of Metaverse Industry
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. COVID-19 Impact on Metaverse Industry
Chapter 5. Market Segmentation 1: By Application Estimates & Trend Analysis
5.1. By Application & Market Share, 2019-2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By Application:
5.2.1. Laboratory Testing
5.2.2. Point-of-Care Testing
Chapter 6. Market Segmentation 2: By Technology Estimates & Trend Analysis
6.1. By Technology & Market Share, 2019-2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By Technology:
6.2.1. Polymerase Chain Reaction (PCR)
6.2.2. Isothermal Nucleic Acid Amplification Technology (INAAT)
6.2.3. Next-Generation Sequencing (NGS)
6.2.4. Immunodiagnostics
6.2.5. Other Technologies
Chapter 7. Market Segmentation 3: By Type of Infection Estimates & Trend Analysis
7.1. By Type of Infection & Market Share, 2019-2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By Type of Infection:
7.2.1.1. Bacterial
7.2.1.2. Viral
7.2.1.3. Fungal
7.2.1.4. Other Infections
Chapter 8. Market Segmentation 4: By Disease Type Estimates & Trend Analysis
8.1. By Disease Type & Market Share, 2019-2031
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By Disease Type:
8.2.1. Respiratory Infections
8.2.2. Sexually Transmitted Infections (STIs)
8.2.3. Gastrointestinal Infections
8.2.4. Other Infections
Chapter 9. Market Segmentation 5: By End-User Estimates & Trend Analysis
9.1. By End-User & Market Share, 2019-2031
9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By End-User:
9.2.1.1. Hospitals and Clinics
9.2.1.2. Diagnostic Laboratories
9.2.1.3. Other End-Users
Chapter 10. Emerging Infectious Disease Diagnostics Market Segmentation 4: Regional Estimates & Trend Analysis
10.1. North America
10.1.1. North America Emerging Infectious Disease Diagnostics Market revenue (US$ Million) estimates and forecasts By Application, 2023-2031
10.1.2. North America Emerging Infectious Disease Diagnostics Market revenue (US$ Million) estimates and forecasts By Technology, 2023-2031
10.1.3. North America Emerging Infectious Disease Diagnostics Market revenue (US$ Million) estimates and forecasts By Type of Infection, 2023-2031
10.1.4. North America Emerging Infectious Disease Diagnostics Market revenue (US$ Million) estimates and forecasts By Disease Type, 2023-2031
10.1.5. North America Emerging Infectious Disease Diagnostics Market revenue (US$ Million) estimates and forecasts By End-User, 2023-2031
10.1.6. North America Emerging Infectious Disease Diagnostics Market revenue (US$ Million) estimates and forecasts by country, 2023-2031
10.1.6.1. U.S.
10.1.6.2. Canada
10.2. Europe
10.2.1. Europe Emerging Infectious Disease Diagnostics Market revenue (US$ Million) by Application, 2023-2031
10.2.2. Europe Emerging Infectious Disease Diagnostics Market revenue (US$ Million) estimates and forecasts By Technology, 2023-2031
10.2.3. Europe Emerging Infectious Disease Diagnostics Market revenue (US$ Million) estimates and forecasts By Type of Infection, 2023-2031
10.2.4. Europe Emerging Infectious Disease Diagnostics Market revenue (US$ Million) estimates and forecasts By Disease Type, 2023-2031
10.2.5. Europe Emerging Infectious Disease Diagnostics Market revenue (US$ Million) estimates and forecasts By End-User, 2023-2031
10.2.6. Europe Emerging Infectious Disease Diagnostics Market revenue (US$ Million) by country, 2023-2031
10.2.6.1. Germany
10.2.6.2. Poland
10.2.6.3. France
10.2.6.4. Italy
10.2.6.5. Spain
10.2.6.6. UK
10.2.6.7. Rest of Europe
10.3. Asia Pacific
10.3.1. Asia Pacific Emerging Infectious Disease Diagnostics Market revenue (US$ Million) by Application, 2023-2031
10.3.2. Asia Pacific Emerging Infectious Disease Diagnostics Market revenue (US$ Million) estimates and forecasts By Technology, 2023-2031
10.3.3. Asia Pacific Emerging Infectious Disease Diagnostics Market revenue (US$ Million) estimates and forecasts By Type of Infection, 2023-2031
10.3.4. Asia Pacific Emerging Infectious Disease Diagnostics Market revenue (US$ Million) estimates and forecasts By Disease Type, 2023-2031
10.3.5. Asia Pacific Emerging Infectious Disease Diagnostics Market revenue (US$ Million) estimates and forecasts By End-User, 2023-2031
10.3.6. Asia Pacific Emerging Infectious Disease Diagnostics Market revenue (US$ Million) by country, 2023-2031
10.3.6.1. China
10.3.6.2. India
10.3.6.3. Japan
10.3.6.4. Australia
10.3.6.5. Rest of Asia Pacific
10.4. Latin America
10.4.1. Latin America Emerging Infectious Disease Diagnostics Market revenue (US$ Million) by Application, 2023-2031
10.4.2. Latin America Emerging Infectious Disease Diagnostics Market revenue (US$ Million) estimates and forecasts By Technology , 2023-2031
10.4.3. Latin America Emerging Infectious Disease Diagnostics Market revenue (US$ Million) estimates and forecasts By Type of Infection, 2023-2031
10.4.4. Latin America Emerging Infectious Disease Diagnostics Market revenue (US$ Million) estimates and forecasts By Disease Type , 2023-2031
10.4.5. Latin America Emerging Infectious Disease Diagnostics Market revenue (US$ Million) estimates and forecasts By End-User, 2023-2031
10.4.6. Latin America Emerging Infectious Disease Diagnostics Market revenue (US$ Million) by country, (US$ Million) 2023-2031
10.4.6.1. Brazil
10.4.6.2. Rest of Latin America
10.5. Middle East & Africa
10.5.1. Middle East & Africa Emerging Infectious Disease Diagnostics Market revenue (US$ Million) by Application, (US$ Million)
10.5.2. Middle East & Africa Emerging Infectious Disease Diagnostics Market revenue (US$ Million) estimates and forecasts By Technology, 2023-2031
10.5.3. Middle East & Africa Emerging Infectious Disease Diagnostics Market revenue (US$ Million) estimates and forecasts By Type of Infection, 2023-2031
10.5.4. Middle East & Africa Emerging Infectious Disease Diagnostics Market revenue (US$ Million) estimates and forecasts By Disease Type, 2023-2031
10.5.5. Middle East & Africa Emerging Infectious Disease Diagnostics Market revenue (US$ Million) estimates and forecasts By End-User, 2023-2031
10.5.6. Middle East & Africa Emerging Infectious Disease Diagnostics Market revenue (US$ Million) by country, (US$ Million) 2023-2031
10.5.6.1. South Africa
10.5.6.2. GCC Countries
10.5.6.3. Rest of MEA
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. Intercontinental Exchange, Inc. (US),
11.2.2. Nasdaq, Inc. (US),
11.2.3. CME Group (US),
11.2.4. AirCarbon Exchange (ACX) (Singapore),
11.2.5. Carbon Trade Exchange (CTX) (UK),
11.2.6. Xpansiv (US),
11.2.7. Carbonplace (England),
11.2.8. Planetly (Germany),
11.2.9. Likvidi (UK),
11.2.10. Toucan (Germany),
11.2.11. BetaCarbon (Australia),
11.2.12. ClimateTrade (US),
11.2.13. Carbon Credit Capital (US),
11.2.14. Flowcarbon (US),
11.2.15. Carbonex (UK)
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們